Wells Fargo’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1 | Hold |
1
| – | – | ﹤0.01% | 6609 |
|
|
2025
Q1 | $1 | Hold |
1
| – | – | ﹤0.01% | 6508 |
|
|
2024
Q4 | $1 | Hold |
1
| – | – | ﹤0.01% | 6496 |
|
|
2024
Q3 | $1 | Hold |
1
| – | – | ﹤0.01% | 6437 |
|
|
2024
Q2 | $1 | Sell |
1
-85
| -99% | -$85 | ﹤0.01% | 6425 |
|
|
2024
Q1 | $357 | Buy |
86
+2
| +2% | +$8 | ﹤0.01% | 5969 |
|
|
2023
Q4 | $271 | Buy |
84
+4
| +5% | +$13 | ﹤0.01% | 6079 |
|
|
2023
Q3 | $239 | Buy |
80
+1
| +1% | +$3 | ﹤0.01% | 6165 |
|
|
2023
Q2 | $90 | Buy |
79
+4
| +5% | +$5 | ﹤0.01% | 6586 |
|
|
2023
Q1 | $126 | Hold |
75
| – | – | ﹤0.01% | 6563 |
|
|
2022
Q4 | $93 | Buy |
75
+2
| +3% | +$2 | ﹤0.01% | 6483 |
|
|
2022
Q3 | $0 | Sell |
73
-8
| -10% | – | ﹤0.01% | 6293 |
|
|
2022
Q2 | $0 | Buy |
81
+6
| +8% | – | ﹤0.01% | 6465 |
|
|
2022
Q1 | $0 | Sell |
75
-12
| -14% | – | ﹤0.01% | 6636 |
|
|
2021
Q4 | $0 | Buy |
87
+26
| +43% | – | ﹤0.01% | 6624 |
|
|
2021
Q3 | $0 | Buy |
61
+12
| +24% | – | ﹤0.01% | 6598 |
|
|
2021
Q2 | $0 | Hold |
49
| – | – | ﹤0.01% | 6521 |
|
|
2021
Q1 | $0 | Buy |
49
+7
| +17% | – | ﹤0.01% | 6484 |
|
|
2020
Q4 | $0 | Hold |
42
| – | – | ﹤0.01% | 6105 |
|
|
2020
Q3 | $0 | Buy |
42
+13
| +45% | – | ﹤0.01% | 5936 |
|
|
2020
Q2 | $0 | Buy |
29
+7
| +32% | – | ﹤0.01% | 5863 |
|
|
2020
Q1 | $0 | Buy |
+22
| New | – | ﹤0.01% | 5818 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5889 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5867 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 5865 |
|